Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global epistaxis device market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, driven by the rising incidence of epistaxis (nosebleeds) across the globe.
Base Year
Historical Year
Forecast Year
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Epistaxis is a medical term used for nosebleeds. Most nosebleeds are mild, self-limiting, and spontaneous, but some can be recurrent. Nosebleeds occur when a blood vessel bursts inside the nose. Epistaxis devices are most widely used for nose bleeding management and, thus, with the rise in functional endoscopic sinus surgery (FESS), the epistaxis device market is witnessing significant growth. As FESS is simple and minimally invasive, it has become the most preferred choice for patients with chronic rhinosinusitis (CRS). FESS is associated with problems that include the use of nasal paddings, such as nasal bleeding and adhesions. The market for epistaxis devices is driven by the rising partnerships and collaborations to bring new devices into the market, along with technical advancements, increased emphasis on early diagnosis and increasing prevalence of diseases like hypertension.
Growth in Product Launches to Boost Market Growth
It is estimated that nearly 60% of people will experience a nosebleed at least once in a lifetime. The occurrence of nosebleeds is also commonly recorded in children aged from 2 to 10 years and adults aged between 55 to 80 years old. In July 2023, NasaClip, Inc., a Baltimore-based medical device company that focuses on developing nose bleed management devices launched an innovative easy-to-use device called NasaClip. The device instantly provides constant, comfortable hands-free compression combined with intranasal sponges to stop the bleeding nose. It is the first FDA-approved device that comes with adjustable nasal compression for children. This cutting-edge development is poised to have a significant impact on the epistaxis market demand triggering competition and more innovations in the market. With curated features such as adjustable compression for children, this innovation is highly capable of being chosen as the first choice of healthcare providers to treat the condition, propelling the market demand.
Surge in Strategic Collaborations to Streamline Nosebleed Treatment
The epistaxis device market demand is driven by the increasing application of these devices in managing the condition. To meet the rising demand for these devices, several companies are collaborating to launch effective and technology-driven devices. For instance, in October 2023, SourceMark Medical, a United States-based medical device company and certified Minority Business Enterprise (MBE), signed a supplier partnership with NasaClip, an easy-to-use nosebleed rescue device available in adult and pediatric sizes to streamline the epistaxis treatment process. As the essence of this partnership is focused on maintaining appropriate supply it can help expand the reach of NasaClip to a wider audience, including hospitals, nursing homes, urgent care centers, schools, and sports facilities. With substantial expansion, the market is collectively poised to experience a higher market value in the forecast period.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Technological Advancements | The market is experiencing continuous technical advancements and innovation in epistaxis devices. This is leading to the development of more effective and user-friendly epistaxis devices, leading to market growth. |
Rising Prevalence of Chronic Conditions | Nasal bleeding is caused due to several underlying factors including chronic diseases such as hypertension. The rising prevalence of chronic conditions such as hypertension, nasal tumours, and nose bleeding disorders, responsible for recurrent nose bleeding is propelling the market growth. |
Minimally Invasive Treatment Options | The rising preference for minimally invasive treatments and procedures for tackling epistaxis is one of the notable market trends, contributing to market growth. |
Increased Awareness and Diagnosis | There is also a significant rise in awareness of epistaxis including causes and risks associated with nose bleeds. This has contributed to an increase in diagnosis incidence. Hence, the demand for effective treatment for epistaxis has increased. |
Market Breakup by Device Type
Market Breakup by Material
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Epistaxis Device Based on Application Leads the Market Share
Based on application, the market segment is categorized into anterior epistaxis treatment, posterior epistaxis treatment, chronic epistaxis treatment, and traumatic epistaxis treatment, among others. The segment is led by anterior epistaxis treatment as anterior nose bleeds are most common, contributing to high prevalence and the majority of cases. The increasing availability of user-friendly, over-the-counter products for anterior nosebleed management is bolstering market demand, and driving growth in the segment.
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Out of these, North America is significantly dominating the market. The dominance can be attributed to the high awareness among people about the available treatments and nosebleed disorders. The presence of a robust healthcare infrastructure and continuous technological development is a major factor justifying the dominance of the market share. The United States alone witnesses more than 500,000 ER visits for nosebleeds on an annual basis. Considering the incidence of ER visits, the requirement of the epistaxis devices is comparatively high hence, contributing to the escalating market demand, justifying the regional dominance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Headquartered in Dublin, Ireland, Medtronic is one of the largest medical device companies in the world. Their product portfolio covers various medical domains including cardiac and vascular devices, minimally invasive therapies, restorative therapies, and diabetes.
Smith & Nephew plc
It is a British multinational medical equipment manufacturing company specialising in the development of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products.
Johnson & Johnson (Ethicon)
Headquartered in New Jersey, USA, Johnson & Johnson (Ethicon) is a multinational pharmaceutical, biotechnology, and medical technologies conglomerate specialising in surgical instruments and technologies.
Stryker Corporation
It is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company has an impressive portfolio across different areas of healthcare including implants used in joint replacement and trauma surgeries, surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment; neurosurgical, neurovascular, and spinal devices and other medical device products.
Cook Group
The Indiana-based company manufactures medical devices such as stents, catheters, vascular products, and devices involved in minimally invasive medicine. Tissue engineering and regenerative medicine products, drug delivery systems, and specialty pharmaceuticals are some of the prominent sectors of development.
Other key players in the market include Olympus Corporation, Boston Scientific Corporation, AbbVie Inc., and Karl Storz SE & Co. KG.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global epistaxis device market is projected to grow at a CAGR of nearly 5.4% in the forecast period of 2024-2032.
The major drivers of the industry include rising disposable incomes, growth in functional endoscopic sinus surgery (FESS), and the rising air pollution.
The technological advancement in epistaxis device materials used after FESS is expected to be a key trend guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.
The leading types of the product in the industry include nasal tampons and nasal catheters, among others.
The major application sectors of the product include anterior and posterior epistaxis.
The leading players in the market are DeRoyal Industries Inc., Pfizer Inc., Stryker Corp., and Teleflex Incorporated, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Device Type |
|
Breakup by Material |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share